News Roundup: March 27-31


Your weekly roundup of the latest news from Drug Topics®.

Higher Dose of Oral Semaglutide More Effective for Patients With T2D

According to a recent study, the diabetes medication semaglutide is more effective as a 25 mg or 50 mg dose on its own, rather than a 14 mg add-on dose with other medications.

Read More

Rezafungin for Injection to Treat Candidemia and Invasive Candidiasis Gets FDA Approval

The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.

Read More

Studying the Impact of Automated Insulin Delivery on Patients With Type 1 and Type 2 Diabetes

Two posters presented at APhA in Phoenix examined the efficacy of the Omnipod® 5 Automated Insulin Delivery System.

Read More

Pharmacy Practitioners Describe Experiences With COVID-19 Misinformation

COVID-19 misinformation is common. A study presented at the annual APhA meeting examined how new pharmacy practitioners responded to misinformation and tried to minimize its spread.

Read More

Video: Tips for Medication Management During Ramadan

Pharmacists can provide support and guidance to patients during their month of fasting.

Read More

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.